So ridiculously cool. Congrats to @neuralink , in which we are proud investors. And what a great way to share this patient's story; can you imagine any big pharma or device company doing a livestream with dogs and videogames. How medical innovation should be done, with fun and
I think it's always worth asking yourself whether a smart stranger could predict your views on an issue merely by knowing where you live, what you do, and some other basic demographics. If yes, your position may be lazy.
Since everyone’s giving hot takes, here’s mine: while I have no affinity for bureaucracies, I’m often impressed by the professionalism and integrity of U.S. government workers, and especially those at the semi-independent agencies like the Fed (or FDIC). It’s impressive how
The striking thing about the LLM-chat products to me is that they expose how mundane and rote most human speaking / "conversation" is. They set a benchmark for boring!
Biomarker interview with @dawallach , GP and co-founder of Time BioVentures.
We discuss his music and tech investing careers, lessons learned and applied to #biotech, areas he finds interesting, and what gets the TimeBV team excited in '23. #biomarkerbiomarker.substack.com/p/time-biovent…
